Insider Stock Trading History of Shandell Jason B.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shandell Jason B. since year 2005. The trader's CIK number is 1611148. At the time of this reporting, Shandell Jason B. is the President and General Counsel of Amphastar Pharmaceuticals, Inc. . (stock ticker symbol AMPH). See this page for all insider trading activities at Amphastar Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Shandell Jason B. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-30 AMPH Amphastar Pharmaceuticals, Inc. Sale 7,828 16.76 131,228
2017-05-31 AMPH Amphastar Pharmaceuticals, Inc. Sale 3,654 17.26 63,071
2016-11-28 AMPH Amphastar Pharmaceuticals, Inc. Sale 24,292 20.47 497,208
2016-11-25 AMPH Amphastar Pharmaceuticals, Inc. Option Ex 2,043 10.93 22,329
2016-11-25 AMPH Amphastar Pharmaceuticals, Inc. Sale 2,043 20.59 42,057
2016-11-28 AMPH Amphastar Pharmaceuticals, Inc. Option Ex 24,292 10.93 265,511
2016-09-26 AMPH Amphastar Pharmaceuticals, Inc. Option Ex 56,996 10.93 622,966
2016-09-26 AMPH Amphastar Pharmaceuticals, Inc. Sale 56,996 19.50 1,111,251
2016-08-22 AMPH Amphastar Pharmaceuticals, Inc. Option Ex 10,000 10.46 104,600
2016-08-22 AMPH Amphastar Pharmaceuticals, Inc. Sale 10,000 19.95 199,500
2016-08-17 AMPH Amphastar Pharmaceuticals, Inc. Sale 5,987 18.86 112,908
2016-08-11 AMPH Amphastar Pharmaceuticals, Inc. Sale 5,636 18.01 101,481
2016-06-09 AMPH Amphastar Pharmaceuticals, Inc. Sale 9,904 16.43 162,722
2016-05-25 AMPH Amphastar Pharmaceuticals, Inc. Sale 1,074 15.60 16,754

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shandell Jason B. (President and General Counsel of Amphastar Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.